1.50656

SeQuant^™ ZIC^®-cHILIC 100Å (3 µm) HPLC Columns

L x I.D. 100 mm x 2.1 mm HPLC Column, PEEK-lined stainless steel

• Synonym(s): Zwitterionic Hydrophilic Interaction Liquid Chromatography HPLC Column
• UNSPSC Code: 41115709
• NACRES: SB.52

Properties

• product name: SeQuant^™ ZIC-cHILIC^™ 3µm,100Å 50 x 2.1 mm, PEEK-lined stainless steel column, suitable for HPLC
• material: PEEK-lined stainless steel column
• Quality Level: 100
• Agency: suitable for USP L114
• product line: SeQuant^™
• feature: endcapped: no
• parameter: 550 bar pressure; 70 °C max. temp.
• technique(s): HPLC: suitable; LC/MS: suitable; UHPLC-MS: suitable; UHPLC: suitable; mass spectrometry (MS): suitable (High)
• column L × I.D.: 5 cm × 2.1 mm
• matrix: fully porous particle
• matrix active group: ZIC-HILIC bonding phase
• particle size: 3 μm
• pore size: 100 Å pore size
• operating pH: 2-7.5
• separation technique: hydrophilic interaction (HILIC)
• storage temp.: no temp limit

Description

General description

SeQuant^™ ZIC^®-HILIC Columns are designed to retain and separate all types of polar and hydrophilic compounds and for robust chromatography with high selectivity and reproducibility. The silica-based ZIC^®-HILIC sorbent has a bonded stationary phase consisting of a highly polar, permanent zwitterion. Separation selectivity is favored by the 1:1 zwitterion charge balance, which makes the ZIC^®-HILIC Column overall neutral, with weak, but important, ionic interactions. Tuning of the selectivity on the ZIC^®-HILIC Column during method development is facilitated by the pH-inpendent permanent zwitterion, ensuring that only the analytes (and not the column) are affected during eluent optimization.The Pore size of 100 Å makes this column perfectly suitable for the separation of small polar molecules under HILIC conditions.The column dimension of 50 mm length x 2.1 mm ID is the optimal choice for the fast separation of polar compounds using a UHPLC or optimized HPLC Instrument providing low dwell volumes.Thanks to their favorable retention and robust performance, SeQuant^™ HILIC columns have become extremely popular in numerous laboratories around the world. For example, US FDA (United States Food and Drug Administration) has recommended SeQuant^™ ZIC^®-HILIC for analysis of melamine and related substances. SeQuant^™ HILIC columns excel in stability and low bleed. These features make them particularly suitable for LC-MS applications where high background can lead to signal suppression and interference with quantitative measurements while also increasing instrument wear. Their high stability makes these high-performance HILIC columns also attractive for traditional HPLC applications.Learn more about the Supelco HPLC Column portfolio and Method development:Brochure: HPLC and UHPLC Column Selection Guide Brochure: A Practical Guide to HPLC - Method Development Guide

Application

• Evaluation of hydrophilic interaction chromatography versus reversed-phase chromatography for fast aqueous species distribution analysis of Nickel(II)-Histidine complex species.: This research compares ZIC-cHILIC with reversed-phase chromatography for analyzing nickel-histidine complexes, emphasizing ZIC-cHILIC′s efficiency in fast aqueous species distribution (Alsaeedi et al., 2023).



• Hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry combined with fabric phase sorptive extraction for therapeutic drug monitoring of pioglitazone, repaglinide, and nateglinide in human plasma.: The study utilizes ZIC-cHILIC in conjunction with mass spectrometry for effective therapeutic drug monitoring in plasma, demonstrating its application in clinical pharmacokinetics (Stamou et al., 2023).



• Comprehensive evaluation of zwitterionic hydrophilic liquid chromatography stationary phases for oligonucleotide characterization.: This article provides a comprehensive assessment of ZIC-cHILIC for oligonucleotide analysis, showcasing its strengths in nucleotide separation and characterization (Lardeux et al., 2023).



• HILIC-MS for Untargeted Profiling of the Free Glycation Product Diversity.: The research highlights the use of ZIC-cHILIC in untargeted metabolomics, specifically in profiling glycation products, demonstrating its versatility in metabolite analysis (Yan et al., 2022).

Legal Information

SeQuant is a trademark of Merck KGaA, Darmstadt, Germany

ZIC is a registered trademark of Merck KGaA, Darmstadt, Germany

ZIC-HILIC is a trademark of Merck KGaA, Darmstadt, Germany